top
Search terms
Results 1 - 10 of 10 - ordered by :
Epeuropace

Warfarin, the most commonly applied VKA, reduces the stroke risk by 64%.1 The major drawbacks of VKA therapy include the risk of bleeding, especially intracranial haemorrhage, many food and drugdrug ...

Europace, Review, T. Lewalter, P. Kanagaratnam, B. Schmidt, M. Rosenqvist, J. E. Nielsen-Kudsk, R. Ibrahim, B. A. Albers, A. J. Camm

Date : 01/05/2014
Epeuropace

When a clinician has to decide on use of antithrombotic drugs in the setting of a patient affected by atrial fibrillation (AF) experiencing an acute coronary syndrome (ACS), the difficult task is ...

Europace, Editorial, Giuseppe Boriani, Deirdre A. Lane, Stephan Windecker, Kurt Huber, Paulus Kirchhof, Gregory Y.H. Lip

Date : 01/09/2015
Ehjcvp

Methods and results In this observational study, 5426 Chinese AF patients (77.7 ± 10.7 years, female: 53.1%) with a CHA2DS2-VASc score of 1 were included in the final analysis: of which, 3832 ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Pak-Hei Chan, Wen-Hua Li, Jo-Jo Hai, Koon-Ho Chan, Hung-Fat Tse, Bernard Man-Yung Cheung, Esther W. Chan, Ian C.K. Wong, ...

Date : 01/10/2015
Ehjournal

Methods and results The Assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II pilot trial compared the safety and efficacy of enoxaparin with UFH in 155 patients with AF who ...

European Heart Journal, Klein, Allan L., Jasper, Susan E., Katz, William E., Malouf, Joseph F., Pape, Linda A., Stoddard, Marcus F., Apperson-Hansen, Carolyn, Lieber, Elizabeth A.

Date : 01/12/2006 Item size : 235804 bytes
Ehjournal

Atrial fibrillation (AF) is the most common sustained arrhythmia, with an estimated prevalence of 6 million among all Europeans.1 This places a huge public health burden in terms of morbidity, ...

European Heart Journal, Pillarisetti, Jayasree, Lakkireddy, Dhanunjaya

Date : 14/12/2014 Item size : 125709 bytes
Ehjournal

Abstract Aims An increased risk of stroke was observed in two atrial fibrillation (AF) trials of oral factor Xa inhibitors, when patients were transitioned to open label warfarin at the end of the ...

European Heart Journal, Azoulay, Laurent, Dell'Aniello, Sophie, Simon, Teresa A., Renoux, Christel, Suissa, Samy

Date : 21/07/2014 Item size : 266070 bytes
Ehjournal

Methods and results The Assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II pilot trial compared the safety and efficacy of enoxaparin with UFH in 155 patients with AF who ...

European Heart Journal, Klein, Allan L., Jasper, Susan E., Katz, William E., Malouf, Joseph F., Pape, Linda A., Stoddard, Marcus F., Apperson-Hansen, Carolyn, Lieber, Elizabeth A.

Date : 01/12/2006 Item size : 241563 bytes
Revistaespanola

In our opinion, the CHA2DS2-VASc scale should not have been used, nor should the European Society of Cardiology 2010 recommendations for oral anticoagulant use, since they were subsequent to the ...

Revista Española de Cardiología

Date : 01/05/2014 Item size : 35119 bytes
Escardio

Background More than a half of the patients with atrial fibrillation (AF) are not adequately anti-coagulated, even though in prevention of ischemic stroke in this patient-population, there is strong ...

Date : 15/07/2013